Analyst Upgrades – AstraZeneca (NYSE:AZN) Stock Gets Upgraded By Jefferies Group from Hold to Buy

Analyst Ratings For AstraZeneca (NYSE:AZN)

Today, AstraZeneca (NYSE:AZN) stock received an upgrade by Jefferies Group from Hold to Buy with a price target of $36.70.

Some recent analyst ratings include

  • 3/19/2018-Jefferies Group Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 12/29/2017-JPMorgan Chase & Co. Upgrade from a “Neutral ” rating to a ” Overweight” rating.
  • 10/18/2017-Citigroup Upgrade from a “Buy” rating to a “” rating.
  • 10/17/2017-Cowen Reiterated Rating of Hold.

Dividend information for AstraZeneca (NYSE:AZN)

AstraZeneca (NYSE:AZN) pays an annual dividend of $1.37 with a yield of 3.96% and an average dividend growth of -21.20% based on a 3 Year Average..

Dividend History for AstraZeneca (NYSE:AZN)

  • On 2/5/2018 AstraZeneca announced a semiannual dividend of $0.95 5.62% with an ex dividend date of 2/15/2018 which will be payable on 3/19/2018.
  • On 7/28/2017 AstraZeneca announced a None dividend of $0.44 2.98% with an ex dividend date of 8/9/2017 which will be payable on 9/11/2017.
  • On 2/3/2017 AstraZeneca announced a semiannual dividend of $0.95 6.81% with an ex dividend date of 2/15/2017 which will be payable on 3/20/2017.
  • On 7/29/2016 AstraZeneca announced a dividend of $0.44 with an ex dividend date of 8/10/2016 which will be payable on 9/12/2016.
  • On 2/5/2016 AstraZeneca announced a dividend of $0.93 with an ex dividend date of 2/17/2016 which will be payable on 3/21/2016.
  • On 2/10/2015 AstraZeneca announced a semiannual dividend of $1.90 5.57% with an ex dividend date of 2/18/2015 which will be payable on 3/23/2015.
  • On 8/1/2014 AstraZeneca announced a semiannual dividend of $0.90 2.48% with an ex dividend date of 8/13/2014 which will be payable on 9/15/2014.


    Recent Trading Activity for AstraZeneca (NYSE:AZN)
    Shares of AstraZeneca closed the previous trading session at with 34.83000183105469 shares trading hands.

    An ad to help with our costs